Tweet

FDA reviews drug ads

By BroadCasting & Cable Staff -- Broadcasting & Cable, 4/1/2001 8:00:00 PM

Facing concerns that patient demand for prescription drugs is needlessly raising the cost of health care, the Food and Drug Administration will begin a long-planned review of the impact of drug ads on TV, the agency announced this week. The aim is to evaluate guidelines established in 1997, when the FDA loosened restrictions for prescription-drug ads. Comments on the design of surveys being created for doctors and patients are due at the FDA May 18.

Tweet

Talkback

We would love your feedback!

Post a comment

» View All Talkback Threads

Related Content

• Topics
• Author
• Most Popular Pages

No related content found.

Also by this author

• Technology Leadership Summit 2011

• WGA Announces TV Noms

• Cable Ratings: 'Top Chef' Finale Draws 3.4 Million

• Leo Wolinsky Named Editor of Daily Variety

• CAB: Cable Ad Spending Grows to $18.7B in '09

Also by Staff Staff

Most Popular Pages

No Top Articles

• Resource Center
• Browse Categories
• Browse Companies

Featured Company

• Mixpo

  

  Mixpo is a video advertising technology provider that enables publishers, ad networks, and agencies to easily deliver dynamically tailored, interactive video ads that are customized in real-time for unique audience segments. Our platform also provides automatic multivariate testi..more

---

Most Recent Resources

• The New Normal for Promoting Tune-in
• Achieving Operational Freedom in Digital Media Workflows